Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · Real-Time Price · USD
169.64
-6.55 (-3.72%)
At close: Jul 31, 2025, 4:00 PM
169.64
0.00 (0.00%)
After-hours: Jul 31, 2025, 4:10 PM EDT

Company Description

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally.

It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing).

The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services.

The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services.

The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products.

This segment offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies.

It utilizes Logica, a platform offering from Valo Health, to identify advanceable small molecule leads.

It provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Charles River Laboratories International, Inc.
Charles River Laboratories International logo
CountryUnited States
Founded1947
IPO DateJun 23, 2000
IndustryDiagnostics & Research
SectorHealthcare
Employees20,100
CEOJames Foster

Contact Details

Address:
251 Ballardvale Street
Wilmington, Massachusetts 01887
United States
Phone781 222 6000
Websitecriver.com

Stock Details

Ticker SymbolCRL
ExchangeNYSE
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001100682
CUSIP Number159864107
ISIN NumberUS1598641074
Employer ID06-1397316
SIC Code8731

Key Executives

NamePosition
James C. Foster J.D.Chairman, President and Chief Executive Officer
Flavia H. PeaseCorporate Executive Vice President and Chief Financial Officer
Birgit GirshickCorporate Executive Vice President and Chief Operating Officer
Joseph W. LaPlume J.D.Corporate Executive Vice President of Corporate Development and Strategy
Victoria L. CreamerCorporate Executive Vice President and Chief People Officer
Michael Gunnar KnellCorporate Senior Vice President and Chief Accounting Officer
Prof. Julie Frearson Ph.D.Corporate Senior Vice President and Chief Scientific Officer
Mark MintzCorporate EVice President, Chief Information Officer and Global Shared Services
Todd SpencerCorporate Vice President of Investor Relations
Matthew L. Daniel J.D.Corporate Senior Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer

Latest SEC Filings

DateTypeTitle
Jul 21, 2025144Filing
Jun 25, 2025144Filing
May 23, 20258-KCurrent Report
May 16, 2025SDForm - SD
May 14, 2025144Filing
May 13, 2025144Filing
May 12, 2025SCHEDULE 13G/AFiling
May 7, 202510-QQuarterly Report
May 7, 20258-KCurrent Report
May 7, 20258-KCurrent Report